BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19887424)

  • 1. Adverse selection in the Medicare prescription drug program.
    Riley GF; Levy JM; Montgomery MA
    Health Aff (Millwood); 2009; 28(6):1826-37. PubMed ID: 19887424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
    Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
    Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare prescription drug plan coverage of pharmacotherapies for opioid and alcohol dependence in WA.
    Kennedy J; Dipzinski A; Roll J; Coyne J; Blodgett E
    Drug Alcohol Depend; 2011 Apr; 114(2-3):201-6. PubMed ID: 21134724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact of Medicare Part D in the end-stage renal disease population.
    St Peter WL
    Adv Chronic Kidney Dis; 2008 Apr; 15(2):140-6. PubMed ID: 18334238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Medicare Part D doughnut hole: effect on pharmacy utilization.
    Sun SX; Lee KY
    Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US.
    Kim MH; Lin J; Kreilick C
    Adv Ther; 2009 Aug; 26(8):784-94. PubMed ID: 19690820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare Part D--the sea of choices meets the donut hole.
    Flaer PJ; Dondériz A; Younis MZ
    J Health Care Finance; 2007; 34(1):1-7. PubMed ID: 18972980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.
    Cubanski J; Neuman P
    Health Aff (Millwood); 2007; 26(1):w1-12. PubMed ID: 17118944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.
    Neuman P; Strollo MK; Guterman S; Rogers WH; Li A; Rodday AM; Safran DG
    Health Aff (Millwood); 2007; 26(5):w630-43. PubMed ID: 17711865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
    De Natale ML
    Policy Polit Nurs Pract; 2007 Aug; 8(3):170-81. PubMed ID: 18178923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Medicare prescription drug plans in four states: balancing cost and access.
    Heaton E; Carino T; Dix H
    Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.